CT

Celldex Therapeutics

CLDX
NASDAQHealth Care

Income Statement

Total Revenue$7.02M
Gross Profit$7.02M
Operating Income$-195.08M
EBITDA$-154.69M
EBIT$-157.86M
Pre-tax Income$-283.65M
Net Income$-157.86M

Balance Sheet

Cash Equivalent$55.64M
Total Debt$2.85M
Book Value$796.3M
Book Value Per Share12.52

Key Ratios

Return on Equity (ROE)-21.13%
Return on Assets (ROA)-19.92%
Return on Invested Capital (ROI)-21.13%
Net Profit Margin-2248.76%
Current Ratio18.91
Quick Ratio18.38
Long-Term Debt / Equity0.00